The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease

Bailliere's Clinical Obstetrics and Gynaecology

Volumn 12, Issue 4, 1998, Pages 607-618

  Lubin, V ^a   Charbonnel, B ^a   Bouchard, P ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Fertility; Follicle stimulating hormone; Gonadotrophin releasing hormone antagonist; In vitro fertilization; Luteinizing hormone; Polycystic ovarian disease; Pregnancy

Indexed keywords

FOLLITROPIN; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; TESTOSTERONE;

ANOVULATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN RELEASE; HUMAN; HYPERANDROGENISM; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; OOCYTE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031751929     PISSN: 09503552     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3552(98)80055-2     Document Type: Article

References (44)

1. Alcalay M Bider D Lipitz S Polycystic ovarian syndrome, pregnancy outcome following in vitro fertilization-embryo transfer Gynecological Endocrinology 9 1995 119 123
2. Ashkenasi J Farhi J Orvieto R Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient Fertility and Sterility 64 3 1995 564 567
3. Balen AH Tan SL Jacobs HS Hypersecretion of luteinizing hormone: a significant cause of infertility and miscarriage British Journal of Obstetrics and Gynaecology 100 1993 1082 1089
4. Bouchard P Charbonnel B Caraty A The role of GnRH during the periovulatory period: a basis for the use of GnRH antagonists in ovulation induction 1994 Excerpta Medica 291 297
5. Buckler HM Phillips SE Kovacs GT GnRH agonist administration in polycystic ovary syndrome Clinical Endocrinology 31 1989 151 165
6. Buyalos RP Lee CT Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization Fertility and Sterility 65 1996 1 10
7. Cedars MI Steingold KA de Ziegler D Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction Fertility and Sterility 57 1992 495 500
8. Charbonnel B Krempf M Blanchard P Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins Fertility and Sterility 47 1987 920 924
9. Chillik CF Itskovitz J Hahn DW Characterizing pituitary response to a gonadotropin-releasing hormone antagonist in monkeys: tonic follicle-stimulating hormone/luteinizing hormone secretion versus acute GnRH challenge tests before, during and after treatment Fertility and Sterility 48 1987 480 487
10. Dodson WC Hughes CL Yancy SE Haney AF Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome Fertility and Sterility 52 1989 915 918
11. Dor J Shulman A Levran D The treatment of polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility Human Reproduction 56 1990 816 818
12. Dubourdieu S Le Nestour E Spitz IM The combination of gonadotrophin-releasing hormone (GnRH) antagonist and pulsatile GnRH normalize luteinizing hormone secretion in polycystic ovarian disease but fails to induce follicular maturation Human Reproduction 8 12 1993 2056 2060
13. Filicori M Butler JP Crowley JWF Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion Journal of Clinical Investigation 73 1984 1638
14. Filicori M Santoro N Merriam GR Crowley WF Jr Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle Journal of Clinical Endocrinology and Metabolism 62 1986 1136 1344
15. Filicori M Flamigni C Campaniello E The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management Journal of Clinical Endocrinology and Metabolism 69 1989 825 831
16. Fleming R Induction of ovulation on polycystic ovarian disease Progress in Clinical and Biological Research 225 1986 401 412
17. Franks S Mason HD Polson DW Mechanism and management of ovulatory failure in women with polycystic ovary syndrome Human Reproduction 4 1988 531 534
18. Frydman R Cornel C De Ziegler D Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotropin releasing hormone antagonist (Nal-Glu) during the late follicular phase Human Reproduction 7 7 1992 930 933
19. Gordon K Williams RF Danforth DR Hodgen GD A novel regimen of gonadotropin-releasing hormone antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction Fertility and Sterility 54 1990 1140 1145
20. Hamilton-Fairley D Kiddy DS Watson H Low dose gonadotropin therapy for induction of ovulation in 100 women with PCOS Human Reproduction 30 1991 154 156
21. Hoffman GE Bergh PA Guzman I Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotropin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle Human Reproduction 8 1993 695 698
22. Homburg R Armar NA Eshel A Influence of serum luteinising hormone concentration on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome British Medical Journal 297 6655 1988 1024 1026
23. Homburg R Feldberg D Berkowitz D In vitro fertilization and embryo transfer for the treatment of patients with polycystic ovary syndrome Fertility and Sterility 60 1993 858 863
24. Johnson P Pearce MJ Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation British Medical Journal 300 1990 154 156
25. Kazer RR Kessel B Yen SSC LH pulse frequency in women with PCO Journal of Clinical Endocrinology and Metabolism 65 1987 223 226
26. Lahlou N Delivet S Bardin CW Changes in gonadotropin and alpha-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males Fertility and Sterility 53 1990 898 905
27. Li TC Serle E Warren MA Cooke ID Is endometrial development in the preimplantation period influenced by high concentration of luteinising hormone in the follicular phase? Human Reproduction 8 1993 1021 1024
28. Loumaye E Engrand P Howles CM O'Dea L Assessment of the role of luteinising hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome Fertility and Sterility 67 5 1997 889 899
29. Mortola JF Sathanandan S Pavlou S Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies Fertility and Sterility 51 1989 957 963
30. Owen JE Davies MC Kingsland CR The use of short regimen of buserilin, a GnRH agonist and human menopausal gonadotropin in assisted conception cycles Human Reproduction 4 1989 749 753
31. Regan L Owen EJ Jacobs HS Hypersecretion of luteinising hormone, infertility, and miscarriage Lancet 336 8724 1990 1141 1144
32. Salat-Baroux J Alvarez S Antoine JM Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization Human Reproduction 3 1988 535 539
33. Santen RJ Bardin CW Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanism Journal of Clinical Investigation 52 1973 2617 2626
34. Schmutzler RK Reichert C Diedrich K Combinated GnRH agonist/gonadotropin stimulation for in-vitro fertilization Human Reproduction 3 supplement 2 1988 29 33
35. Sengoku K Tamate T Takuma N The chromosomal normality of unfertilized oocytes in polycystic ovarian syndrome Human Reproduction 12 3 1997 474 477
36. Stanger JD Yovich JL Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase British Journal of Obstetrics and Gynaecology 92 1985 385 393
37. Surrey ES De Ziegler D Lu JKH Effects of gonadotropin-releasing hormone agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease Fertility and Sterility 52 1989 547 552
38. Takahashi K Eda Y Abu-Musa A Transvaginal ultrasound imaging, histopathology, and endocrinopathy in patients with polycystic ovary syndrome Human Reproduction 9 1994 1231 1236
39. Tarlatzis BC Grimbizis G The significance of high follicular phase luteinising hormone levels in the treatment of women with polycystic ovary syndrome Journal of Assisted Reproduction and Genetics 14 1 1997 1 4
40. Tarlatzis BC Grimbizis G Pournaropoulos F The prognosis value of basal luteinising hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovary syndrome by assisted reproduction techniques Human Reproduction 10 1995 2545 2549
41. Turhan NO Artini PG D'Ambrogio G A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program Journal of Assisted Reproduction and Genetics 10 1993 15 20
42. Waldstreicher J Santoro NF Hall JE Hyperfunction of the hypothalamic-pituitary axis in women with PCO Journal of Clinical Endocrinology and Metabolism 66 1988 165 172
43. Watson H Kiddy DS Hamilton-Fairley D Hypersecretion of luteinising hormone and ovarian steroid in women with recurrent early miscarriage Human Reproduction 8 1993 829 833
44. White DM Polson DW Kiddy D Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women Journal of Clinical Endocrinology and Metabolism 81 11 1996 3821 3824